Novavax Inc (NVAX)

Deferred Revenue

$86.58M

Quarterly · Period ending: · USD

NVAX logo

NVAX Deferred Revenue

Latest reported$86.58M
NVAX Quarterly Deferred Revenue ($0.00 → $86.58M)
High-resolution chart · PNG

NVAX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.